Rapid Push vs Pump-Infused Subcutaneous Immunoglobulin Treatment: a Randomized Crossover Study of Quality of Life in Primary Immunodeficiency Patients

PURPOSE: Subcutaneous immunoglobulin replacement therapy (IgRT) may be administered once a week with a pump or every other day with a syringe (rapid push). The objective of the study was to compare the impact of pump and rapid push infusions on patient’s life quality index (LQI). METHODS: This study...

Descripción completa

Detalles Bibliográficos
Autores principales: Bienvenu, Boris, Cozon, Grégoire, Mataix, Yves, Lachaud, Dominique, Alix, Antoine, Hoarau, Cyrille, Antier, Daniel, Hachulla, Eric, Brice, Sylvie, Viallard, Jean-François, Tamisier, Stéphanie, Fauchais, Anne-Laure, Renon-Carron, Françoise, Clerson, Pierre, Fardini, Yann, Crave, Jean-Charles, Miossec, Pierre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6028863/
https://www.ncbi.nlm.nih.gov/pubmed/29855752
http://dx.doi.org/10.1007/s10875-018-0507-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6028863/
https://www.ncbi.nlm.nih.gov/pubmed/29855752
http://dx.doi.org/10.1007/s10875-018-0507-x

Ejemplares similares